Reflections on a potential federal drug formulary: Medicines industry response to CDA consultation

Areas of work

• Access to medicine
• Pan-Canadian Pharmaceutical Alliance (pCPA)
• Patented Medicine Prices Review Board (PMPRB)
• Pharmacare